(Oct. 19, 2022) — A little over a year ago President Biden proposed a plan to set in place a new health agency to drive the U.S. down a futuristic road that would lead to cures for cancer, Alzheimer’s, diabetes and other diseases.
At the time, investigative journalist Whitney Webb, author of “One Nation Under Blackmail,” warned that the new biomedical research agency — modeled after the nation’s Defense Advanced Research Projects Agency (DARPA) — actually is a plan to merge national security with health “security” in a way that would “use both physical and mental health ‘warning signs’ to prevent outbreaks of disease or violence before they occur.”1
According to Webb, “Such a system is a recipe for a technocratic ‘pre-crime’ organization with the potential to criminalize both mental and physical illness as well as ‘wrongthink.’”
ARPA-H — A ‘High-Risk’ Research Agency
That agency — formally named the Advanced Research Projects Agency for Health2 (ARPA-H) — is now well on its way to being and up and running, with a $1 billion budget from Congress to start. Public law 117-103 was enacted March 15, 2022, which authorized its establishment within the U.S. Department of Health and Human Services (DHHS), under the National Institutes of Health (NIH).3
Government officials only need to iron out details such as what programs and activities it will engage in, and (of course) what “appropriate” current and future funding will be needed to run it.
ARPA-H seems to fit hand in glove with Biden’s September 12, 2022, “Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe and Secure American Bioeconomy,”4 which essentially establishes a fast-tracked pipeline for transhumanist dream projects.
Specified in that order is the development of genetic engineering technologies and techniques “to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers,” as well as genetic technologies to “unlock the power of biological data” using “computing tools and artificial intelligence.”
Additionally, “obstacles for commercialization” will be reduced “so that innovative technologies and products can reach markets faster.” ARPA-H is a tailor-made vehicle for fast-tracked (read poorly tested and incredibly dangerous) biomedical research. Like DARPA, ARPA-H will focus on “high-risk, high-reward research.”
Task Force Calls for Psych Screening All Adults
In related news, the U.S. Preventive Services Task Force — an independent panel of experts appointed by the Agency for Healthcare Research and Quality, an agency within the Department of Health and Human Services — is recommending that all U.S. adults aged 65 and younger should be screened for mental health issues.5
Is this a forerunner for Webb’s prediction of how the government will detect mental health “pre-crimes”? The task force is accepting public comments on the proposal until October 17, 2022.6
Health and Biowarfare Have Become Increasingly Entwined
While we often think of military defense and public health as two very different areas of concern, the two have over the years merged to a significant extent, which in some ways helps explain why the Centers for Disease Control and Prevention is now acting in ways that can best be described as a covert war against the health of the American public.
In June 2002, President Bush signed the “Biodefense for the 21st Century”7 directive, the aim of which was to advance a “comprehensive framework” for U.S. biodefense, based on the assumption that America could be devastated by a bioweapons attack.
The directive outlined “essential pillars” of the U.S. biodefense program, including threat awareness and vulnerability assessment, prevention and protection, surveillance and detection, response and recovery.
In 2002, the Bush administration quintupled biodefense spending to $317 million, and the following year, that budget ballooned to $2 billion.8 Bush also earmarked another $6 billion for the development and stockpiling of vaccines over the next decade.
The man selected by Vice President Dick Cheney to oversee the spending of much of these vast amounts of cash was Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984.
In 2003, Fauci’s professional responsibilities were expanded to include all civilian biodefense research, both classified and unclassified, and the development of medical countermeasures against terrorist threats from infectious diseases9 — and all without oversight. For all these years, he’s had carte blanche to approve and run whatever biodefense research he wanted, without anyone telling him otherwise.
Read the rest here or download the article:
For all of Dr. Mercola’s archived content, see his “Censored Library” here (subscription required).